Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
sitagliptin (januvia) (1 trial)
Diabetes Mellitus, Type 2 (Phase 1)
Hypertriglyceridemia (Phase 1)
Trials (1 total)
Trial APIs (2 total)